Reports Q3 revenue $711.69M, consensus $724.08M. “Our team has demonstrated its continued strength in execution and excelled operationally, delivering strong results despite very challenging market conditions,” said Dr. Udit Batra, President & CEO, Waters Corporation. “U.S. and Europe pharma growth was again solid in the quarter and exceeded our expectations. However, China fell below our expectations as weakness moved beyond pharma into the industrial and academic and government segments.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WAT: